Reviva Pharmaceuticals Holdings, Inc. (RVPH)
0.5324
-0.01
(-1.12%)
USD |
OTCM |
Sep 09, 16:00
Reviva Pharmaceuticals Holdings Total Assets (Quarterly) : 21.14M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.14M |
| March 31, 2026 | 23.56M |
| December 31, 2025 | 15.92M |
| September 30, 2025 | 14.33M |
| June 30, 2025 | 11.63M |
| March 31, 2025 | 7.077M |
| December 31, 2024 | 15.50M |
| September 30, 2024 | 7.630M |
| June 30, 2024 | 8.053M |
| March 31, 2024 | 13.50M |
| December 31, 2023 | 23.70M |
| September 30, 2023 | 5.387M |
| June 30, 2023 | 11.84M |
| March 31, 2023 | 12.90M |
| December 31, 2022 | 18.92M |
| September 30, 2022 | 24.04M |
| June 30, 2022 | 20.64M |
| Date | Value |
|---|---|
| March 31, 2022 | 25.27M |
| December 31, 2021 | 31.40M |
| September 30, 2021 | 33.89M |
| June 30, 2021 | 36.53M |
| March 31, 2021 | 6.658M |
| February 28, 2021 | |
| November 30, 2020 | |
| August 31, 2020 | |
| May 31, 2020 | |
| February 29, 2020 | 61.02M |
| November 30, 2019 | 66.47M |
| August 31, 2019 | 66.27M |
| May 31, 2019 | 65.99M |
| February 28, 2019 | 65.65M |
| November 30, 2018 | 65.34M |
| August 31, 2018 | 65.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Jaguar Health, Inc. | 34.19M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.933M |
| Shareholders Equity (Quarterly) | 15.21M |
| Debt to Equity Ratio | 0.0095 |
| Current Ratio | 3.563 |
| Net Debt Paydown Yield | 0.19% |